CN101076513A - 药用二硫化物盐 - Google Patents

药用二硫化物盐 Download PDF

Info

Publication number
CN101076513A
CN101076513A CNA200580035465XA CN200580035465A CN101076513A CN 101076513 A CN101076513 A CN 101076513A CN A200580035465X A CNA200580035465X A CN A200580035465XA CN 200580035465 A CN200580035465 A CN 200580035465A CN 101076513 A CN101076513 A CN 101076513A
Authority
CN
China
Prior art keywords
compound
formula
group
ions
bond
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA200580035465XA
Other languages
English (en)
Chinese (zh)
Inventor
Q·黄
H·科查特
X·陈
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BioNumerik Pharmaceuticals Inc
Original Assignee
BioNumerik Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BioNumerik Pharmaceuticals Inc filed Critical BioNumerik Pharmaceuticals Inc
Publication of CN101076513A publication Critical patent/CN101076513A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
    • C07C323/66—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfo, esterified sulfo or halosulfonyl groups, bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CNA200580035465XA 2004-09-21 2005-09-21 药用二硫化物盐 Pending CN101076513A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/945,809 US7282602B2 (en) 2004-09-21 2004-09-21 Medicinal disulfide salts
US10/945,809 2004-09-21

Publications (1)

Publication Number Publication Date
CN101076513A true CN101076513A (zh) 2007-11-21

Family

ID=36074969

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA200580035465XA Pending CN101076513A (zh) 2004-09-21 2005-09-21 药用二硫化物盐

Country Status (7)

Country Link
US (1) US7282602B2 (enExample)
EP (1) EP1797031A4 (enExample)
JP (1) JP5015781B2 (enExample)
CN (1) CN101076513A (enExample)
CA (1) CA2580802C (enExample)
MX (1) MX2007003174A (enExample)
WO (1) WO2006034327A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115397405A (zh) * 2020-01-10 2022-11-25 蓝腾制药公司 确定对2,2’-二硫代双乙烷磺酸盐的敏感性的方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011067653A1 (en) * 2009-12-04 2011-06-09 Carlo Ghisalberti Oral compositions for use in the mercury intoxication from dental amalgam
JP6271233B2 (ja) * 2013-11-29 2018-01-31 ローム・アンド・ハース電子材料株式会社 表面処理液
WO2015106240A1 (en) 2014-01-13 2015-07-16 The General Hospital Corporation Heteroaryl disulfide compounds as allosteric effectors for increasing the oxygen-binding affinity of hemoglobin

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE593047A (enExample) * 1959-07-17
DE2025538A1 (de) * 1970-04-02 1971-10-21 Lokomotivbau Elektrotech Verfahren zur galvanischen Glanzverkupferung aus sauren Elektrolyten
BE788685A (nl) * 1971-09-13 1973-03-12 Agfa Gevaert Nv Ontwikkeling van contrastrijke zilverhalogenide-emulsies voor grafischedoeleinden
DD122086A1 (enExample) * 1975-06-16 1976-09-12
IT1185551B (it) * 1985-04-15 1987-11-12 Schering Spa Composizioni farmaceutiche a base di acido mercaptoetansolfonico ad attivita' terapeutica,derivati salini organici dell'acido mercaptoetansolfonico utili per tali composizioni e relativo procedimento di preparazione
DE4032864A1 (de) * 1990-10-13 1992-04-16 Schering Ag Saures bad zur galvanischen abscheidung von kupferueberzuegen und verfahren unter verwendung dieser kombination
DE4127821A1 (de) * 1991-08-23 1993-02-25 Basf Ag Disulfide, verfahren zu deren herstellung und deren verwendung
US5789000A (en) * 1994-11-14 1998-08-04 Bionumerik Pharmaceuticals, Inc. Sterile aqueous parenteral formulations of cis-diammine dichloro platinum
US5661188A (en) * 1995-06-07 1997-08-26 Medical Research Foundation and Infrastructure Development for Health Services--Nahariya Hospital Branch Therapeutic uses for sodium 2-mercaptoethanesulphonate (mesna)
CA2263166C (en) * 1996-09-23 2006-12-12 Bionumerik Pharmaceuticals, Inc. Reducing toxic effects of carboplatin using dithioethers
ES2163197T3 (es) * 1996-10-01 2002-01-16 Bionumerik Pharmaceuticals Inc Procedimiento para producir ditiobis-alcanosulfonatos y fosfonatos.
US6160167A (en) * 1998-04-21 2000-12-12 Bionumerik Pharmaceuticals, Inc. Mercaptans and disulfides
JP3124523B2 (ja) * 1999-01-28 2001-01-15 日本エレクトロプレイテイング・エンジニヤース株式会社 銅メッキ方法
KR20020029626A (ko) * 2000-10-13 2002-04-19 마티네즈 길러모 전해질
JP2003072231A (ja) * 2001-09-06 2003-03-12 Oji Paper Co Ltd インクジェット記録用シート
US6504049B1 (en) * 2002-04-30 2003-01-07 Bionumerik Pharmaceuticals, Inc. Process for synthesizing pharmaceutically active disulfide salts
KR100598994B1 (ko) * 2002-12-25 2006-07-07 닛코킨조쿠 가부시키가이샤 특정골격을 갖는 4급아민화합물 중합체 및 유기유황화합물을 첨가제로서 포함하는 동전해액 및 그것에 의하여 제조되는 전해동박
JP2005048256A (ja) * 2003-07-30 2005-02-24 Asahi Denka Kogyo Kk 銅メッキ用添加剤、銅メッキ浴および銅メッキ方法
JP2006104134A (ja) * 2004-10-06 2006-04-20 Asahi Denka Kogyo Kk ジスルフィド類の製造方法
JP4750486B2 (ja) * 2005-07-06 2011-08-17 株式会社Adeka 電解銅メッキ用添加剤、該添加剤を含有する電解銅メッキ浴及び該メッキ浴を使用する電解銅メッキ方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115397405A (zh) * 2020-01-10 2022-11-25 蓝腾制药公司 确定对2,2’-二硫代双乙烷磺酸盐的敏感性的方法

Also Published As

Publication number Publication date
MX2007003174A (es) 2008-01-11
US20060063949A1 (en) 2006-03-23
EP1797031A1 (en) 2007-06-20
US7282602B2 (en) 2007-10-16
CA2580802A1 (en) 2006-03-30
WO2006034327A1 (en) 2006-03-30
JP2008513503A (ja) 2008-05-01
CA2580802C (en) 2012-11-20
EP1797031A4 (en) 2009-12-16
JP5015781B2 (ja) 2012-08-29

Similar Documents

Publication Publication Date Title
CN1249744A (zh) 一氧化氮合成酶抑制剂
US9603828B2 (en) Sulforaphane isolation and purification
PT2616068T (pt) Pró-fármacos ésteres de [3-(1-(1h-imidazol-4-il)etil)-2-metilfenil]metanol para abaixamento da pressão intraocular
CN1089336C (zh) 有抗炎和肌肉松驰活性的秋水仙碱和硫代秋水仙碱衍生物
US8450089B2 (en) Compounds as L-cystine crystallization inhibitors and uses thereof
EP1109779B1 (en) Novel mercaptans and disulfides
CN101076513A (zh) 药用二硫化物盐
CN1902167A (zh) 合成二硫化物的方法
US8466309B2 (en) Amino acid derivatives, method for preparing same, and therapeutic use thereof
US20150099806A1 (en) Compounds as l-cystine crystallization inhibitors and uses thereof
CN1344263A (zh) 多环的2－氨基噻唑体系、它们的制备方法和包含这些化合物的药物
US7829539B2 (en) Compounds and methods for reducing undesired toxicity of chemotherapeutic agents
CN1133626C (zh) 双氯芬酸偶联衍生物、其合成方法及抗炎作用
CN1230887A (zh) 采用二硫醚降低碳铂的毒性作用
CN1490329A (zh) 咪唑啉取代的苯氧乙酰寡肽类衍生物，它们的合成及在医学中的应用
CN1341107A (zh) 多环的2－氨基二氢噻唑体系、它们的制备方法和它们作为药物的用途
JPH0686419B2 (ja) システイン関連化合物
EP0430800B1 (fr) Nouvelles benzothiazolinones substituées, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
CN101597276A (zh) N-(α,β-二巯基-β-羧基丙酰基)-氨基酸的丙叉衍生物及其合成方法和应用
CN1082511C (zh) 含磷的金雀花碱衍生物
PL147352B1 (en) Method of obtaining novel racemic or optically active derivatives of interfuranylno-prostacyclin
CN87104927A (zh) 1-羟基-5-氧代-5H-吡啶并[3，2-a]吩嗪-3-羧酸酯的制备方法
JPH0526765B2 (enExample)
JPS632257B2 (enExample)
CA2432807A1 (fr) Derives de 1, 1-dioxo-2h-1, 2-benzothiazine-3-carboxamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20071121